Clinical trial
Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic…
NCT00004806 · University of Alabama at Birmingham, Other · Completed
Key facts
| NCT number | NCT00004806 |
|---|---|
| Title | Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Genetic |
| Interventions | Cystic fibrosis transmembrane conductance regulator |
| Enrollment | 9 |
| Start date | Jun 1, 1995 |
| Primary completion | Nov 1, 2002 |
| Completion | Nov 1, 2002 |
| First posted | Feb 25, 2000 |
| Last update posted | Mar 30, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: